Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure

Affiliations

Free article

Editorial

Michael J Rauh. J Am Coll Cardiol. 2021.

Free article

. 2021 Apr 13;77(14):1760-1762.

doi: 10.1016/j.jacc.2021.02.045.

¹ Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: michael.rauh@queensu.ca.

No abstract available

Keywords: CHIP; DNMT3A; TET2; aging; heart failure; somatic mutation.

Conflict of interest statement

Funding Support and Author Disclosures Dr. Rauh has reported that he has no relationships relevant to the contents of this paper to disclose.

Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA, Bayes-Genis A, Díez-Díez M, Hernández-Vicente Á, Vázquez-Andrés D, de la Barrera J, Vazquez E, Quintas A, Zuriaga MA, Asensio-López MC, Dopazo A, Sánchez-Cabo F, Fuster JJ. Pascual-Figal DA, et al. J Am Coll Cardiol. 2021 Apr 13;77(14):1747-1759. doi: 10.1016/j.jacc.2021.02.028. J Am Coll Cardiol. 2021. PMID: 33832602